Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Inter-Appointment Pain in Symptomatic Apical Periodontitis
NCT07014397Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2024
- Primary completion
- Mar 2025
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, triple-blind trial in apical periodontitis (AP) comparing Valacyclovir Group with Placebo Group (2 arms). Primary endpoint: Pain intensity measured by Visual Analog Scale at 48 hours. Started Nov 2024; status: completed.
02
Drugs
valaciclovir
03
Conditions
apical periodontitis (AP)
Beyond the preview
Go deeper on NCT07014397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07014397.